NDC codes

382549 NDC codes with hospital pricing data in the network.

• NDC 00407-2223-06 — IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION (10 hospitals, 6,050 samples)
• NDC 00407-2223-60 — IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION (10 hospitals, 6,050 samples)
• NDC 00407-2223-63 — IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION (10 hospitals, 6,050 samples)
• NDC 00781910572 — OLANZAPINE 10 MG INTRAMUSCULAR SOLUTION (57 hospitals, 1,189–6,040 samples)
• NDC 00409-1159-18 — BUPIVACAINE (PF) 0.25 % (2.5 MG/ML) INJECTION SOLN (62 hospitals, 5,859–6,039 samples)
• NDC 60687012201 — predniSONE 5 mg Tab (188 hospitals, 4,131–6,039 samples)
• NDC 00173087306 — INCRUSE ELLIPTA 62.5 MCG-ACT IN AEPB (200 hospitals, 4,968–6,030 samples)
• NDC 00591292754 — Levalbuterol Tartrate (114 hospitals, 4,923–6,030 samples)
• NDC 70092148646 — PHENYLEPH 80MCG/ML 10ML NS SYG (38 hospitals, 5,256–6,030 samples)
• NDC 70092111249 — HYDROMORPHONE (PF) 6 MG/30 ML (0.2 MG/ML) IN 0.9% NACL IV PCA SYRINGE (61 hospitals, 5,256–6,030 samples)
• NDC 73177010516 — MORPHINE (PF) 30 MG/30 ML(1 MG/ML) IN 0.9% SOD.CHLORIDE IV PCA SYRINGE (32 hospitals, 5,256–6,030 samples)
• NDC 70004030321 — HYDROMORPHONE 1 MG/ML PCA/INFUSION,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% IV SOLN 50 MG/50ML,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% IV SOLN 100 MG/100ML,HYDROMORPHONE HCL-NACL SOLN PREF SYR 50 MG/50ML-0.9%,HYDROMORPHONE HCL-NACL SOLN PREF SYR 55 MG/55ML-0.9%,HYDROMORPHONE HCL-NACL SOLN PREF SYR 30 MG/30ML-0.9%,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% IV SOLN 30 MG/30ML,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% IV SOLN 150 MG/150ML,HYDROMORPHONE HCL-NACL SOLN PREF SYR 15 MG/15ML-0.9%,HYDROMORPHONE HCL-NACL SOLN PREF SYR 25 MG/25ML-0.9%,HYDROMORPHONE HCL-NACL INJ SOLN PREF SYR 30 MG/30ML-0.9%,HYDROMORPHONE HCL IV SOLN 1 MG/ML,HYDROMORPHONE HCL IV SOLN PREF SYR 50 MG/50ML,HYDROMORPHONE HCL-NACL INJ SOLN PREF SYR 25 MG/25ML-0.9%,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% INJ 50 MG/50ML,HYDROMORPHONE HCL-SODIUM CHLORIDE 0.9% INJ 100 MG/100ML (33 hospitals, 5,256–6,030 samples)
• NDC 09991271500 — LIDOCAINE 2% (5 ML) + BUPIVACAINE 0.75% (5 ML) (21 hospitals, 5,256–6,030 samples)
• NDC 00009001820 — METHYLPREDNISOLONE NA SUC (PF) 1000 MG IJ SOLR (185 hospitals, 3,254–6,026 samples)
• NDC 00173069504 — FLUTICASONE-SALMETEROL 100-50 MCG/ACT IN AEPB (100 hospitals, 4,991–6,017 samples)
• NDC 63323049101 — lidocaine PF 5 mg/mL (0.5 %) solution 50 mL Vial (97 hospitals, 4,500–6,003 samples)
• NDC 69374094604 — 69374-0946-04 - labetalol 20 mg / 4 mL Soln-IV (139 hospitals, 1,790–6,002 samples)
• NDC 70121100005 — methylPREDNISolone sodium succinate 40 mg PowderIn (80 hospitals, 3,408–6,000 samples)
• NDC 76329330401 — CALCIUM CHLORIDE 10 % IV SOLN (337 hospitals, 5,100–6,000 samples)
• NDC 70121100001 — METHYLPREDNISOLONE SODIUM SUCC 40 MG IJ SOLR CUSTOM (44 hospitals, 3,408–6,000 samples)
• NDC 00173069604 — ADVAIR 250-50 DISKUS (109 hospitals, 4,989–5,997 samples)
• NDC 63323-0360-19 — INJECTION, CALCIUM GLUCONATE, NOT OTHERWISE SPECIFIED, 10 MG (205 hospitals, 5,900–5,990 samples)
• NDC 69194055501 — CEFUROXIME(PF) 4 MG/0.4 ML IN 0.9% SODIUM CHLORIDE INTRAOCULAR SYRINGE (24 hospitals, 5,241–5,988 samples)
• NDC 63323006403 — Magnesium Sulfate (361 hospitals, 2,580–5,982 samples)
• NDC 00143938101 — DOXYCYCLINE HYCLATE 100 MG IV SOLR (76 hospitals, 4,146–5,982 samples)
• NDC 00409115919 — BUPIVACAINE HCL (PF) 0.25 % IJ SOLN (130 hospitals, 2,038–5,980 samples)
• NDC 60505615101 — 60505-6151-01 - cefTRIAXone 250 mg Powder (103 hospitals, 3,751–5,974 samples)
• NDC 71266200102 — succinylcholine 200 mg/10 mL Soln-IV 10 mL SDV (145 hospitals, 5,175–5,967 samples)
• NDC 70860030105 — Diltiazem Hydrochloride: 10 Vial In 1 Carton (70860-301-05) / 5 Ml In 1 Vial (70860-301-41) (146 hospitals, 4,924–5,932 samples)
• NDC 00409176110 — BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) IN 8.25 % DEXTROSE INJECTION (153 hospitals, 1,386–5,931 samples)
• NDC 72603021201 — dexAMETHasone (45 hospitals, 4,764–5,925 samples)
• NDC 09990518900 — DEXAMETHASONE 1 MG/ML DROPS (CONCENTRATE) (22 hospitals, 4,764–5,925 samples)
• NDC 51079-0285-20 — diazePAM (142 hospitals, 5,670–5,922 samples)
• NDC 71285701801 — EPINEPHRINE HCL 4 MG/250 ML (16 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS (79 hospitals, 5,170–5,917 samples)
• NDC 71285010201 — CARDIOPLEGIC SOLUTION NO.10 108 MEQ/500 ML (POTASSIUM) FOR PERFUSION (60 hospitals, 5,170–5,917 samples)
• NDC 71285809301 — EPINEPHRINE HCL 4 MG/250 ML (16 MCG/ML) IN 0.9 % SODIUM CHLOR IV SOLN (29 hospitals, 5,170–5,917 samples)
• NDC 71506003405 — SUCCINYLCHOLINE CHLORIDE 100 MG/5 ML (20 MG/ML) INTRAVENOUS SYRINGE (34 hospitals, 5,170–5,917 samples)
• NDC 61141143703 — HYDROMORPHONE 6 MG/30 ML (0.2 MG/ML) IN 0.9 % NACL IV PCA SYRINGE (20 hospitals, 5,170–5,917 samples)
• NDC 15082063068 — GENTAMICIN 0.3 MG/ML SODIUM CITRATE 3 ML CATHETER DWELL (20 hospitals, 5,170–5,917 samples)
• NDC 09990548300 — HYDROMORPHONE (PF) 1 MG/ML IN 0.9 % SODIUM CHLORIDE INTRAVENOUS SOLN (20 hospitals, 5,170–5,917 samples)
• NDC 00054418125 — Dexamethasone Tab 1 Mg (138 hospitals, 4,493–5,915 samples)
• NDC 60505615201 — Ceftriaxone Sodium For Inj 500 MG (146 hospitals, 3,902–5,909 samples)
• NDC 60687-0112-21 — ANASTROZOLE 1 MG TABLET (101 hospitals, 5,668–5,902 samples)
• NDC 63323006401 — MAGNESIUM SULFATE 50 % IJ SOLN (220 hospitals, 2,045–5,897 samples)
• NDC 16714069001 — Propofol IV Emul 1000 MG/100ML (10 MG/ML) (47 hospitals, 3,632–5,882 samples)
• NDC 17478003005 — fentaNYL 250 mcg/5 mL Soln-Inj (101 hospitals, 4,247–5,867 samples)
• NDC 25682-0001-01 — RITUXIMAB-ARRX 10 MG/ML INTRAVENOUS SOLUTION (211 hospitals, 5,841–5,859 samples)
• NDC 70860030142 — DILTIAZEM HCL 25 MG/5ML IV SOLN (91 hospitals, 4,904–5,858 samples)
• NDC 00143985801 — CEFTRIAXONE 500 MG INJ SOLR IM (75 hospitals, 3,706–5,857 samples)
• NDC 00338-0017-31 — DEXTROSE 5 % IN WATER (D5W) INTRAVENOUS SOLUTION (49 hospitals, 5,172–5,856 samples)